News Update

PM to hold roadshow in Puri on MondayViolations of economic sanctions: Criminal penalties come into forceBengaluru Customs nabs 4 pax with gold powder worth Rs 1.96 CroreKejriwal’s assistant put in police custody for 5 days in Swati Maliwal caseAllahabad HC upholds decision to dismiss judicial officer demanding dowryNawaz Sharif alleges former Chief Justice plotted to oust him as PM in 2017Heavy downpours claim 50 lives in Central AfghanistanSoaring funeral costs compelling people to let go bodies unclaimed in Canada9 pilgrims burnt to death as bus catches fire near Nuh in HaryanaSpain denies dock permission to Indian ship carrying arms to Israel12 Unicorns, over 125 startups commit to onboarding ONDCBEML secures Rs 250 crore order from Northern Coal FieldsBharat Parv celebration takes centerstage at Cannes Film FestivalSteel industry should work towards reducing emissions: Steel SecretaryI-T - Additions framed on account of unexplained cash credit & unexplained money, are not tenable where cash deposits & withdrawals were of personal funds & were done through banking channels: ITATUS says not too many vibrant democracies in the world than IndiaI-T - Benefit of section 11(2) can not be denied merely on reasoning that form 10 is filed belatedly: ITATIndia says Chabahar Port to benefit Central Asia and AfghanistanRussia seizes Italy’s UniCredit assets worth USD 463 mnCus - Order re-determining transaction value based on CRCL test report is not correct & hence unsustainable: CESTATCus - If price is not sole consideration for sale, then transaction value can be rejected under Rule 8 of Export Valuation Rules & then must be redetermined sequentially through Rules 4 to 6: CESTATSC upholds ICAI rules capping number of audits per year
 
CX – Excess quantity filled in Injection is as per provisions of Drugs & Cosmetics Rules, 1945 and hence appellant is not required to pay any duty thereon - Appeal allowed: CESTAT

By TIOL News Service

MUMBAI, MAR 02, 2014: THE appellant is a medicament manufacturer.

The facts of the case are mentioned thus – "During the course of manufacturing activity, they drew control sample for testing and not paid duty on that. The appellant has also procured certain inputs which were used as trial on machine and as required by the Drugs & Cosmetics Rules, they have to fill excess quantity in the injection, therefore, revenue is of the view that appellant are required to pay duty on the excess quantity involved in the injection sold by them."

Be that as it may, SCN was issued to the appellant demanding CE duty and the same was confirmed by the CCE, Belapur along with penalty and interest.

The appellant has accepted the duty demand raised for control sample and inputs used in the machine trial but in respect of the remaining part of the order viz. excess quantity in injection sold, the appellant contests the same before the CESTAT.

After hearing both sides, the Single Member Bench observed that in the matter of duty liability on 'Control sample', the Tribunal in the case of Dabur India Ltd. 2005-TIOL-171-CESTAT-DEL-LB has held that control samples retained in factory are not liable to duty if proper account is maintained. Inasmuch as since the appellant was maintaining proper account for control samples they are not required to any pay duty although they are not contesting duty liability. And so, they are also not required to pay interest and penalty for not paying duty on control samples. As regards inputs used in trial run of machine, the same are entitled for CENVAT credit in view of the decision in Kolsite Machine FabrikP. Ltd. 2004 (176) ELT 673 but since the appellant is not contesting the issue the interest and penalty was waived.

In the matter of payment of duty on the 'excess quantity in the injection' the Bench observed that since filling of excess quantity is mandated by the provisions of the Drugs & Cosmetics Rules, 1945, the appellant is not required to pay duty on the same. And therefore, question of penalty and interest also does not arise.

The appeals were disposed of in the above manner.

(See 2014-TIOL-323-CESTAT-MUM)


POST YOUR COMMENTS
   

TIOL Tube Latest

Shri N K Singh, recipient of TIOL FISCAL HERITAGE AWARD 2023, delivering his acceptance speech at Fiscal Awards event held on April 6, 2024 at Taj Mahal Hotel, New Delhi.


Shri Ram Nath Kovind, Hon'ble 14th President of India, addressing the gathering at TIOL Special Awards event.